Followers | 46 |
Posts | 7114 |
Boards Moderated | 0 |
Alias Born | 07/18/2020 |
Sunday, June 04, 2023 10:13:04 AM
then it is no longer sufficient for this Court to ignore
Chevron. Whatever theoretical benefits might have
been perceived with Chevron when it was decided,
decades of practice have exposed its many flaws. To
begin with, Chevron “wrests from Courts the ultimate
interpretative authority to ‘say what the law is’” and
places it in the executive’s hands. Michigan, 576 U.S.
at 761 (Thomas, J., concurring). When a law is truly
unambiguous, there is little need for statutory
construction. The whole business of statutory
construction concerns statutory text that at least one
of the litigants perceives to be ambiguous. Thus, a
doctrine that defers to the executive at the first sign of
ambiguity is nothing short of an “abdication of the
judicial duty.” Gutierrez-Brizuela, 834 F.3d at 1152
(Gorsuch, J., concurring).
Moreover, precisely because the judiciary is
weakened under Chevron, the doctrine also
encourages the executive branch’s aggrandizement at
the expense of the judiciary, Congress, and the citizenry. It is no accident that the Code of Federal
Regulation has burgeoned during the Chevron era. It
is far easier to gin up ambiguity in a statute than it is
to run the gauntlet of bicameralism and presentment.
Compare Ramos v. Louisiana, 140 S.Ct. 1390, 1413
(2020) (Kavanaugh, J., concurring in part) (“Both by
design and as a matter of fact, enacting new
legislation is difficult.”), with Kent Barnett &
Christopher J. Walker, Chevron in the Circuit Courts,
116 Mich. L. Rev. 1, 33-34 (2017) (sampling over 1,000
cases and concluding that courts of appeals find
ambiguity at Chevron step one 70% of the time).
Worse still, it is far harder for Congress to enact new
legislation when one party or the other can rely on
their friends in the executive branch to fix the problem
without the hassle and accountability that comes with
actually legislating."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM